Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.770
-0.040 (-0.83%)
At close: Jan 2, 2026, 4:00 PM EST
4.820
+0.050 (1.05%)
After-hours: Jan 2, 2026, 7:33 PM EST
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $917.39 million as of January 2, 2026. Its market cap has increased by 36.37% in one year.
Market Cap
917.39M
Enterprise Value
828.29M
1-Year Change
36.37%
Ranking
Category
Stock Price
$4.77
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $917.39M, an increase of 1,831.34%. That is a compound annual growth rate of 20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 917.40M | -0.83% |
| Dec 31, 2025 | 925.10M | 49.31% |
| Dec 31, 2024 | 619.60M | 47.81% |
| Dec 29, 2023 | 419.20M | 14.98% |
| Dec 30, 2022 | 364.60M | -30.71% |
| Dec 31, 2021 | 526.20M | 74.59% |
| Dec 31, 2020 | 301.40M | 90.76% |
| Dec 31, 2019 | 158.00M | -25.65% |
| Dec 31, 2018 | 212.50M | -23.56% |
| Dec 29, 2017 | 278.00M | 106.85% |
| Dec 30, 2016 | 134.40M | -44.65% |
| Dec 31, 2015 | 242.80M | -28.19% |
| Dec 31, 2014 | 338.10M | 196.58% |
| Dec 31, 2013 | 114.00M | 89.05% |
| Dec 31, 2012 | 60.30M | 289.03% |
| Dec 30, 2011 | 15.50M | -68.04% |
| Dec 31, 2010 | 48.50M | 2.11% |
| Dec 31, 2009 | 47.50M | - |
| Dec 31, 2009 | 47.50M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.07B |
| Johnson & Johnson | 497.06B |
| AbbVie | 404.25B |
| UnitedHealth Group | 301.25B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.68B |
| Novo Nordisk | 227.63B |